Idexx Laboratories Stock Alpha and Beta Analysis
IDXX Stock | USD 541.89 2.32 0.43% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as IDEXX Laboratories. It also helps investors analyze the systematic and unsystematic risks associated with investing in IDEXX Laboratories over a specified time horizon. Remember, high IDEXX Laboratories' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to IDEXX Laboratories' market risk premium analysis include:
Beta 1.01 | Alpha (0.16) | Risk 1.74 | Sharpe Ratio (0.01) | Expected Return (0.02) |
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
IDEXX |
IDEXX Laboratories Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. IDEXX Laboratories market risk premium is the additional return an investor will receive from holding IDEXX Laboratories long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in IDEXX Laboratories. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate IDEXX Laboratories' performance over market.α | -0.16 | β | 1.01 |
IDEXX Laboratories expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of IDEXX Laboratories' Buy-and-hold return. Our buy-and-hold chart shows how IDEXX Laboratories performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.IDEXX Laboratories Market Price Analysis
Market price analysis indicators help investors to evaluate how IDEXX Laboratories stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading IDEXX Laboratories shares will generate the highest return on investment. By understating and applying IDEXX Laboratories stock market price indicators, traders can identify IDEXX Laboratories position entry and exit signals to maximize returns.
IDEXX Laboratories Return and Market Media
The median price of IDEXX Laboratories for the period between Fri, Dec 29, 2023 and Thu, Mar 28, 2024 is 551.21 with a coefficient of variation of 3.34. The daily time series for the period is distributed with a sample standard deviation of 18.3, arithmetic mean of 547.39, and mean deviation of 16.14. The Stock received a lot of media exposure during the period. Price Growth (%) |
Timeline |
1 | IDEXX Laboratories Updates FY24 Earnings Guidance | 02/05/2024 |
2 | Disposition of 483 shares by Jonathan Mazelsky of IDEXX Laboratories at 206.94 subject to Rule 16b-3 | 02/21/2024 |
3 | IDEXX Laboratories Rebounded After Significant Drawdown From July Highs | 02/22/2024 |
4 | Disposition of 1404 shares by Sophie Vandebroek of IDEXX Laboratories at 245.79 subject to Rule 16b-3 | 03/05/2024 |
5 | Idexx Down 1.5 percent Since Last Earnings Report Can It Rebound | 03/06/2024 |
6 | Disposition of 680 shares by James Polewaczyk of IDEXX Laboratories at 559.3318 subject to Rule 16b-3 | 03/07/2024 |
7 | Executive Vice President James Polewaczyk Sells Shares of IDEXX Laboratories Inc | 03/08/2024 |
8 | 100 Invested In IDEXX Laboratories 5 Years Ago Would Be Worth This Much Today | 03/11/2024 |
9 | IDEXX Laboratories, Inc. Stock Has Shown Weakness Lately But Financials Look Strong Should Prospective Shareholders Make The Leap | 03/12/2024 |
10 | IDEXX Laboratories earnings growth rate lags the 19 percent CAGR delivered to shareholders | 03/19/2024 |
11 | Heres How Much You Would Have Made Owning IDEXX Laboratories Stock In The Last 20 Years | 03/27/2024 |
About IDEXX Laboratories Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including IDEXX or other stocks. Alpha measures the amount that position in IDEXX Laboratories has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
2021 | 2022 | 2023 | 2024 (projected) | Price Earnings Ratio | 75.32 | 50.24 | 54.56 | 57.29 | Short Term Coverage Ratios | 5.09 | 0.83 | 2.79 | 2.65 |
IDEXX Laboratories Upcoming Company Events
As portrayed in its financial statements, the presentation of IDEXX Laboratories' financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, IDEXX Laboratories' leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of IDEXX Laboratories' public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of IDEXX Laboratories. Please utilize our Beneish M Score to check the likelihood of IDEXX Laboratories' management manipulating its earnings.
5th of February 2024 Upcoming Quarterly Report | View | |
7th of May 2024 Next Financial Report | View | |
31st of December 2023 Next Fiscal Quarter End | View | |
5th of February 2024 Next Fiscal Year End | View | |
30th of September 2023 Last Quarter Report | View | |
31st of December 2022 Last Financial Announcement | View |
Build Portfolio with IDEXX Laboratories
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out IDEXX Laboratories Backtesting, IDEXX Laboratories Valuation, IDEXX Laboratories Correlation, IDEXX Laboratories Hype Analysis, IDEXX Laboratories Volatility, IDEXX Laboratories History and analyze IDEXX Laboratories Performance. For more information on how to buy IDEXX Stock please use our How to Invest in IDEXX Laboratories guide.You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Complementary Tools for IDEXX Stock analysis
When running IDEXX Laboratories' price analysis, check to measure IDEXX Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy IDEXX Laboratories is operating at the current time. Most of IDEXX Laboratories' value examination focuses on studying past and present price action to predict the probability of IDEXX Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move IDEXX Laboratories' price. Additionally, you may evaluate how the addition of IDEXX Laboratories to your portfolios can decrease your overall portfolio volatility.
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |
IDEXX Laboratories technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.